Onward to 2016.

Q3 Medicine

Journal of Circulating Biomarkers Pub Date : 2016-01-28 eCollection Date: 2016-01-01 DOI:10.5772/62278

Shidong Jia, Antonio Chiesi, Winston Patrick Kuo

引用次数: 0

Abstract

As we embrace for another exciting year (2016), we are thrilled to announce JCB has been indexed in the DOAJ (Directory of Open Access Journals) (https://doaj.org/toc/ 1849-4544)! This was attributable to the number of quality published original research articles in 2015 with the help of our Associate Editors and Editorial Board. We published several papers covering each of the main topics within the scope of the journal from cell-free DNA, circulating tumour cells and extracellular vesicles to circulating proteins. In addition, we opened a new technology forum presenting the latest technology and published its first article entitled, “Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization” by Shannon Werner and her colleagues.

查看原文本刊更多论文

进入2016年。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Circulating Biomarkers Medicine-Biochemistry (medical)

CiteScore

3.20

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal. Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.